Tumor-specific targeting of intravenous 131 I-chlorotoxin ( 131 I-TM-601) in patients with metastatic melanoma

Fiveash, J. B. ; Conry, R. M. ; Shen, S.

Texto completo disponível

A phase III multi-institutional randomized study of immunization with the gp100: 209–217(210M) peptide followed by high-dose IL-2 compared with high-dose IL-2 alone in patients with metastatic melanoma

Schwartzentruber, D. J. ; Lawson, D. ; Richards, J. ; Conry, R. M. ; Miller, D. ; Triesman, J. ; Gailani, F. ; Riley, L. B. ; Vena, D. ; Hwu, P.

Texto completo disponível

A phase III multi-institutional randomized study of immunization with the gp100: 209–217(210M) peptide followed by high-dose IL-2 compared with high-dose IL-2 alone in patients with metastatic melanoma

Schwartzentruber, D. J. ; Lawson, D. ; Richards, J. ; Conry, R. M. ; Miller, D. ; Triesman, J. ; Gailani, F. ; Riley, L. B. ; Vena, D. ; Hwu, P.

Texto completo disponível

A phase III multi-institutional randomized study of immunization with the gp100: 209–217(210M) peptide followed by high-dose IL-2 compared with high-dose IL-2 alone in patients with metastatic melanoma

Schwartzentruber, D. J. ; Lawson, D. ; Richards, J. ; Conry, R. M. ; Miller, D. ; Triesman, J. ; Gailani, F. ; Riley, L. B. ; Vena, D. ; Hwu, P.

Texto completo disponível

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)

Agarwala, Sanjiv S ; Lee, Sandra J ; Yip, Waiki ; Rao, Uma N ; Tarhini, Ahmad A ; Cohen, Gary I ; Reintgen, Douglas S ; Evans, Terry L ; Brell, Joanna M ; Albertini, Mark R ; Atkins, Michael B ; Dakhil, Shaker R ; Conry, Robert M ; Sosman, Jeffrey A ; Flaherty, Lawrence E ; Sondak, Vernon K ; Carson, William E ; Smylie, Michael G ; Pappo, Alberto S ; Kefford, Richard F ; Kirkwood, John M

United States: American Society of Clinical Oncology

Texto completo disponível

Phase III, randomized, double blind, placebo-controlled trial of sorafenib in desmoid tumors (Alliance A091105)

Gounder, Mrinal M. ; Mahoney, Michelle R. ; Van Tine, Brian Andrew ; Ravi, Vinod ; Attia, Steven ; Deshpande, Hari Anant ; Gupta, Abha A. ; Milhem, Mohammed M. ; Conry, Robert Martin ; Movva, Sujana ; Pishvaian, Michael J. ; Crawford, Jeffrey ; Sabagh, Tarek ; Maki, Robert G. ; Tap, William D. ; Lefkowitz, Robert A ; Agaram, Narasimhan P ; Wright, John Joseph ; Dueck, Amylou C. ; Schwartz, Gary K.

Texto completo disponível

A randomized phase II study of ipilimumab at 3 (ipi3) or 10 mg/kg (ipi10) alone or in combination with high dose interferon-alfa (HDI) in advanced melanoma (E3611)

Tarhini, Ahmad A. ; Lee, Sandra J. ; Rao, Uma N. M. ; Nagarajan, Arun ; Albertini, Mark R. ; Mitchell, Jerry W ; Wong, Stuart J. ; Taylor, Mark A. ; Laudi, Noel ; Truong, Phu Van ; Conry, Robert Martin ; Kirkwood, John M.

Texto completo disponível

Phase I trial of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of WT p53 in patients with solid tumors and lymphomas

Meric-Bernstam, Funda ; Saleh, Mansoor N. ; Infante, Jeffrey R. ; Goel, Sanjay ; Falchook, Gerald Steven ; Shapiro, Geoffrey ; Chung, Ki Y ; Conry, Robert Martin ; Hong, David S. ; Wang, Judy Sing-Zan ; Steidl, Ulrich ; Walensky, Loren D. ; Guerlavais, Vincent ; Payton, Marie ; Annis, D. Allen ; Aivado, Manuel ; Patel, Manish R.

Texto completo disponível

First-in-human dose-escalating trial of E.coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors

Chung, Thomas Kenwise ; Rosenthal, Eben ; Parker, William B ; Allan, Paula ; Clemons, Lisa ; Lowman, Deborah ; Hong, Jeong ; Hunt, Frank R ; Richman, Joshua ; Conry, Robert Martin ; Mannion, Kyle ; Carroll, William ; Nabell, Lisle ; Sorscher, Eric J

Texto completo disponível